...
click to view more

Crispr-Cas-Based Genome Editing for Treating Human Diseases - Part B: Volume 210

by Crispr-Cas-Based Genome Editing for Treating Human Diseases - Part B: Volume 210

$196.99

add to favourite
  • In Stock - Guaranteed to ship in 24 hours with Free Online tracking.
  • FREE DELIVERY by Friday, April 11, 2025 1:28:06 PM UTC
  • 24/24 Online
  • Yes High Speed
  • Yes Protection
Tell-A-Friend
Last update:

Description

CRISPR-Cas-Based Genome Editing for Treating Human Diseases, Part B represents CRISPR-Cas systems for genome editing. Currently, CRISPR-Cas systems have been proven to be a key technology for targeted genome editing, which is acting as a simple, rapid, and cost-effective solution. Chapters in this release include Current approaches in CRISPR -Cas systems for metabolic disorders, Recent progress in CRISPR -Cas systems for CRISPR for retinal diseases, Recent progress in CRISPR -Cas systems for cataract and blindness, Advances in CRISPR -Cas systems for muscular dystrophy, Recent development in CRISPR -Cas systems for cardiac disease, Current approaches in CRISPR -Cas systems for diabetes, and much more.

Additional sections cover Advances in CRISPR -Cas systems for liver disease, Advances in CRISPR -Cas systems for lung disease, Advances in CRISPR -Cas systems for kidney diseases, Current progress in CRISPR -Cas systems for rare disease, Advances in CRISPR -Cas systems for heredity disease, Recent progress in CRISPR -Cas systems for neurological disorders, and CRISPR challenges in clinical developments.

Last updated on

Product Details

  • Academic Press Brand
  • Jan 22, 2025 Pub Date:
  • 9780443224201 ISBN-13:
  • 044322420X ISBN-10:
  • 308.0 pages Hardcover
  • English Language
  • 9 in * 0.96 in * 6 in Dimensions:
  • 1 lb Weight: